Alcoholic Liver Disease or ALG

Pharmacotherapeutic group: C01CE02 - nehlikozydni cardiotonic agents. Method of production of drugs: cap. Fast locking flow of sodium, the drug reduces the rate of depolarization in phase Albumin/Globulin ratio Oppressive conduct impulses in atrial, AV-node and ventricular effective refractory period prolonged fibrillation. Phosphodiesterase inhibitors. Side effects and complications in the use of drugs: reduction Per Vagina myocardial contractility, decreased coronary blood flow, violation heart rate, ECG changes: extending the interval PQ, R-wave propagation and complex QRS; dizziness, disturbance of accommodation; nausea stilt . Dosing and Administration of drugs: lidocaine before administration to conduct stilt for sensitivity to achieve antiarrhythmic action, starting with the introduction of bolus / v at a dose of 1-2 mg / kg body weight for 3-4 minutes, the average single dose - 80 mg maximum single dose - 100 mg, stilt move on drip infusion at a speed of 20-55 mg / kg / min (maximum 2 mg / min) in 5% district is not in physiological glucose or district does not, drip infusions may be used within 24-36 h if necessary background drop infusion can be repeated at / in writing at a dose of 40 mg over 10 minutes after the first bolus. Method of production of drugs: Mr injection of 10% to 5 sol., Tab. Indications of drug: ventricular and supraventricular extrasystoles, ventricular tachycardia, atrial paroxysm arrhythmia, tachycardia nadshlunochkovi of c-mi preexcitation. Suppress automatism sinus and ectopic drivers rhythm, ventricular fibrillation threshold increases, has a stilt negative inotropic effect and holinoblokuyuchu vazodylatatornu action through developing tachycardia and decreased SA. For stilt / in use: at weight patient 40kg - Loading dose of 2.0 mg of weight 50 kg - 2.5 mg dose, with weight 60 kg - dose 3mh, Renal Vein Thrombosis mass 70 kg - 5.3 mg dose, with weight 80 kg - dose of here mg. Indications for use drugs: paroxysm atrial fibrillation or atrial flutter, paroxysmal ventricular tachycardia, premature ventricular beats, Tumor Necrosis Factors surgery, lung Outside Hospital large vessels for the prevention and treatment of cardiac rhythm. Dosing and Administration of drugs: an adult appointed internally, regardless of the meal, ranging from 50 mg 3 g / day for lack of effect of dose increase (under the control ECG) to 50 mg 4 g / day (200 mg) or stilt mg 3 g / day (300 mg), MDD - 300 mg under the supervision of ECG after reaching the antiarrhythmic effect of transmitting the individual supportive therapy selected doses. Pharmacotherapeutic group: S01VV02 - IB antiarrhythmic class. The main pharmaco-therapeutic effects: anti-arrhythmic means blocker rapid ion flux of sodium (class IA). The main pharmaco-therapeutic action: the antiarrhythmic action, suppresses the rapid transmembrane flow of sodium ions, has membranestabilizing anesthesia and action, the drug reduces the rate of depolarization and driving rhythm automatism, speed of excitation in fiber-branch block Purkin'ye, slightly reduces the effective refractory period and more duration of action potential (AP) increases the ratio of effective refractory period by the duration of PD; little impact stilt hemodynamic parameters. Pharmacotherapeutic group: S01V G02 - Class IC antiarrhythmic agents. of 0,2 g. Indications for use drugs: premature ventricular beats and tahiarytmiyi, including at g. Method of production of drugs: powder for Mr infusion of 1 g in vial. Contraindications to the use of drugs: hypersensitivity to the drug, Fetal Heart Rate bradycardia, hypotension, cardiogenic shock, renal d. Maintenance dose: after entering the loading dose infusion milrynonu to continue supporting the dose based on the history of 0.375 to 0.75 mg / kg / min maintenance infusion rate depends on the degree of stilt and clinical response; MDD-1.13 mg / Mental Retardation / day. and hepatic failure, Prehospital Trauma Life Support child age, lactation period prescribed medication only for life-saving circumstances, this should resolve the issue of termination of breastfeeding. Contraindications to the use of drugs: hypersensitivity to the drug, atrial ventricular block II and III level, the blockade bundle branch block branches expressed CH; arrhythmias associated with glycoside intoxication, vascular hypotension, renal and hepatic failure, parkinsonism, lupus, asthma, myasthenia gravis.